Trials / Unknown
UnknownNCT04305288
Chemotherapy mFOLFIRINOX in Locally Advanced or Metastatic Cholangiocarcinoma
Modified FOLFIRINOX Versus Gemcitabine Plus Oxaliplatin as First-line Chemotherapy for Patients With Locally Advanced or Metastatic Cholangiocarcinoma
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Shanghai Jiao Tong University School of Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study was to evaluate the effectiveness of modified FOLFIRINOX (mFOLFIRINOX) compared to that of gemcitabine plus oxaliplatin (Gemox) for patients with locally advanced or metastatic CCA
Detailed description
The aim of this study was to evaluate the effectiveness of modified FOLFIRINOX (mFOLFIRINOX) compared to that of gemcitabine plus oxaliplatin (Gemox) for patients with locally advanced or metastatic CCA
Conditions
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2020-12-01
- Completion
- 2021-12-01
- First posted
- 2020-03-12
- Last updated
- 2021-01-05
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04305288. Inclusion in this directory is not an endorsement.